Coming November 4: ASH publishes its abstracts and its oral and poster sessions. We’ll add the institutions presenting them as they become publicly available.

Astellas at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Astellas exhibits at Booth 3512 at ASH 2026 in New Orleans. Astellas supports a symposium on current approaches to managing acute myeloid leukemia. It is built as a second-opinion review of patient cases.

OrganizationASH 2026 Attendance
Astellas
Tokyo, Japan
astellas.com/us
Large pharma
Global pharmaceutical company based in Tokyo developing medicines for unmet medical needs, including therapies for acute myeloid leukemia.
Booth
Exhibiting at Booth 3512
Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm
Symposium
Fri Dec 11
7:00am–10:00am
Current Management Paradigms in Acute Myeloid Leukemia – A Second Opinion Case Review
Difficult acute myeloid leukemia cases where doctors sought second opinions, paired with reviews of recent data, current management, and ongoing trials.
Sheraton New Orleans · Napoleon Ballroom AB
Leukemias

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Astellas

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction